making muscle wasting history

Idebenone

• Last Edited: 26 Aug 2009
• Permanent link

Santhera Pharmaceuticals Holding AG (SWF:SANN) Publication In European Heart Journal Highlights Potential Of Santhera’s SNT-MC17/idebenone In Duchenne Muscular Dystrophy Tuesday, September 3...

Tags: idebenone, santhera, heart, cardiac, clinical trial, Heart treatment.

New developments in the treatment of Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

• Last Edited: 5 May 2009
• Permanent link

Phase III Clinical trial planned for SNT-MC17/idebenone (brand name Catena®) treatment In Duchenne Muscular Dystrophy progressive muscle weakness in patients results in respiratory and cardiac ill...

Tags: Santhera, idebenone, Catena, antioxidant, DELPHI.

Idebenone

• Last Edited: 15 Jul 2009
• Permanent link

The absence of dystrophin does not only weaken the cell membranes but also negatively affects the mitochondria in the muscle cells of Duchenne patients. In these “power stations” of the ...

Tags: Idebenone, Friedreichs ataxia, cardiomyopathy.